Intrua Financial LLC Sells 4,970 Shares of Aflac Incorporated $AFL

Key Points

• Intrua Financial LLC reduced its position in Aflac by 57%, selling nearly 5,000 shares, resulting in ownership of 3,754 shares valued at $417,000 by the end of the most recent reporting period.
• Analysts have mixed views on Aflac, with target price adjustments ranging from $98.00 to $110.00, and a consensus rating of "Hold" among 13 analysts covering the stock.
• Aflac reported a quarterly earnings per share of $1.78, exceeding estimates, though revenue was down 19% year-over-year at $4.16 billion.

Intrua Financial LLC lessened its holdings in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 57.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,754 shares of the financial services provider's stock after selling 4,970 shares during the quarter. Intrua Financial LLC's holdings in Aflac were worth $417,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. NorthRock Partners LLC grew its position in shares of Aflac by 1.5% in the 1st quarter. NorthRock Partners LLC now owns 6,519 shares of the financial services provider's stock valued at $725,000 after purchasing an additional 95 shares during the period. Valued Wealth Advisors LLC increased its position in shares of Aflac by 24.4% during the first quarter. Valued Wealth Advisors LLC now owns 495 shares of the financial services provider's stock worth $55,000 after acquiring an additional 97 shares in the last quarter. Phillips Wealth Planners LLC raised its holdings in shares of Aflac by 1.5% during the first quarter. Phillips Wealth Planners LLC now owns 6,653 shares of the financial services provider's stock worth $711,000 after acquiring an additional 100 shares during the period. Optas LLC raised its holdings in shares of Aflac by 3.5% during the first quarter. Optas LLC now owns 2,949 shares of the financial services provider's stock worth $328,000 after acquiring an additional 101 shares during the period. Finally, Apexium Financial LP lifted its position in Aflac by 3.4% in the 1st quarter. Apexium Financial LP now owns 3,103 shares of the financial services provider's stock valued at $345,000 after acquiring an additional 103 shares in the last quarter. 67.44% of the stock is currently owned by institutional investors.

Aflac Stock Performance

Aflac stock traded down $0.83 during midday trading on Monday, reaching $108.30. 1,834,958 shares of the company's stock were exchanged, compared to its average volume of 2,208,083. The stock's 50-day simple moving average is $104.09 and its 200 day simple moving average is $105.17. The firm has a market cap of $57.92 billion, a price-to-earnings ratio of 24.56, a P/E/G ratio of 3.05 and a beta of 0.85. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.11 and a current ratio of 0.11. Aflac Incorporated has a 52 week low of $96.95 and a 52 week high of $115.50.

Aflac (NYSE:AFL - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The financial services provider reported $1.78 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.71 by $0.07. Aflac had a return on equity of 15.08% and a net margin of 15.32%.The company had revenue of $4.16 billion during the quarter, compared to analysts' expectations of $4.30 billion. During the same period last year, the firm posted $1.83 earnings per share. The business's revenue was down 19.0% on a year-over-year basis. On average, analysts expect that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Aflac Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 2nd. Shareholders of record on Wednesday, August 20th were given a dividend of $0.58 per share. This represents a $2.32 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date of this dividend was Wednesday, August 20th. Aflac's payout ratio is 52.61%.

Aflac announced that its board has initiated a share repurchase program on Tuesday, August 12th that authorizes the company to buyback 100,000,000 shares. This buyback authorization authorizes the financial services provider to reacquire shares of its stock through open market purchases. Stock buyback programs are often an indication that the company's board believes its stock is undervalued.

Wall Street Analyst Weigh In

Several research firms have issued reports on AFL. Evercore ISI reissued an "underperform" rating and issued a $106.00 price target (up previously from $105.00) on shares of Aflac in a research note on Thursday, August 14th. Wall Street Zen upgraded Aflac from a "sell" rating to a "hold" rating in a research note on Saturday, August 9th. UBS Group reduced their price target on Aflac from $114.00 to $111.00 and set a "neutral" rating for the company in a research report on Wednesday, August 6th. Raymond James Financial lowered their price objective on shares of Aflac from $115.00 to $110.00 and set an "outperform" rating on the stock in a report on Thursday, May 29th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Aflac from $96.00 to $100.00 and gave the stock a "neutral" rating in a research report on Tuesday, July 8th. Three research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have assigned a Sell rating to the company's stock. According to data from MarketBeat, Aflac presently has an average rating of "Hold" and an average target price of $109.15.

Insider Buying and Selling at Aflac

In other news, Director Joseph L. Moskowitz sold 1,000 shares of the stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $102.57, for a total value of $102,570.00. Following the transaction, the director directly owned 25,105 shares of the company's stock, valued at $2,575,019.85. This represents a 3.83% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.80% of the stock is owned by insiders.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.